Cardio Diagnostics Holdings: Revolutionizing Cardiovascular Disease Prevention and Detection with AI-Powered Precision Medicine

Wednesday, Apr 1, 2026 3:37 pm ET1min read
CDIO--

Cardio Diagnostics Holdings (CDIO) is a precision cardiovascular medicine company that uses artificial intelligence and biomarkers to detect and manage cardiovascular disease. The company's non-invasive, blood-based tests can identify coronary heart disease that traditional methods may miss. CDIO has established multiple commercialization channels and recently expanded into India and secured CMS reimbursement rates.

Cardio Diagnostics Holdings: Revolutionizing Cardiovascular Disease Prevention and Detection with AI-Powered Precision Medicine

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet